Robert F. Bruns - Concepedia

Author

Robert F. Bruns

Eli Lilly (United States)ORCID

Also Known As

Bruns, Robert F., R F Bruns, R. F. BRUNS, R. F. Bruns, R.F. Bruns, ROBERT F. BRUNS, Robert F Bruns, Robert F. Bruns

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Warde Medical Laboratory National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health

About

Robert F. Bruns is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	43	5.2K
2	Natural Sciences	15	15	1.5K
3	Social Sciences	6	6	1.8K
4	Health Sciences	2	2	82
5	Engineering	1	1	574

Robert F. Bruns

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Robert F. Bruns, Gina H. Lu, Thomas A. Pugsley Molecular Pharmacology	1986	832
Adenosine receptors and behavioral actions of methylxanthines. Solomon H. Snyder, Jefferson J. Katims, Zoltan Annau, Proceedings of the National Academy of Sciences Molecular PharmacologyAdenosine ReceptorsBehavioral NeuroscienceNeurophysiologyCaffeine Produce	1981	702
A rapid filtration assay for soluble receptors using polyethylenimine-treated filters Robert F. Bruns, Karen Lawson-Wendling, Thomas A. Pugsley Analytical Biochemistry EngineeringRapid Filtration AssayCapillary ElectrophoresisMedicineAnalytical Chemistry	1983	574
Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Robert F. Bruns, John W. Daly, Solomon H. Snyder Proceedings of the National Academy of Sciences Adenosine ReceptorsGuinea Pig BrainCellular PhysiologySocial SciencesMolecular Pharmacology	1980	550
Subclasses of angiotensin II binding sites and their functional significance. David T. Dudley, Robert L. Panek, Terry C. Major, Molecular Pharmacology	1990	378
Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes Robert F. Bruns, James H. Fergus, Edward W. Badger, Naunyn-Schmiedeberg s Archives of Pharmacology BiochemistryNeurophysiologyMedicineNeuropeptide ReceptorNeuropharmacology	1987	377
Inhibition of protein kinase C by calphostin C is light-dependent Robert F. Bruns, Freeman D. Miller, Ronald L. Merriman, Biochemical and Biophysical Research Communications Light RegulationPhotoreceptor CellSignal TransductionSignaling PathwayBiochemistry	1991	369
Rules for Identifying Potentially Reactive or Promiscuous Compounds Robert F. Bruns, Ian Watson Journal of Medicinal Chemistry Pharmaceutical ResearchChemical AnalysisBiological AssaysOrganic ChemistryCompound Class	2012	332
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes. Robert F. Bruns, James H. Fergus Molecular Pharmacology	1990	250
Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists Robert F. Bruns Canadian Journal of Physiology and Pharmacology Molecular PharmacologyAdenosine Receptor ActivationMolecular PhysiologySignal TransductionBiochemistry	1980	196

Page 1